Login to Your Account

Washington Roundup

New Biosimilar Path Is Anything But Predictable

By Mari Serebrov
Washington Editor

Monday, February 13, 2012
WASHINGTON – While the package of draft guidances the FDA released last week on biosimilars held no surprises, it also was light on the specifics needed to produce predictability in the new pathway.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription